Research and Markets: Global Top 10 Biotechnology Companies - Industry, Financial and SWOT Analysis: Comprehensive View of the Global Biotechnology Industry and Its Top 10 Companies
* Reuters is not responsible for the content in this press release.
DUBLIN--(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/1baa00/global_top_10_biot) has announced the addition of the "Global Top 10 Biotechnology Companies - Industry, Financial and SWOT Analysis" report to their offering. Scope: 'Top 10 Global Biotechnology Companies Report: Strategic evaluation of industry and key players' is a business report that provides a comprehensive view of the global biotechnology industry and its top 10 companies. The report includes the following: * Industry analysis including market value, market volume, market share and forecast growth till 2012 * Assessment of intensity of competition based on five-forces model including degree of rivalry, substitutes, new entrants, buyer power and supplier power * SWOT and 5-year financial analysis of top 10 players in the industry * Descriptive profiles of the leading players including the strategic initiatives undertaken by them in the last 12 months The top 10 companies have been ascertained based on their global revenues for the financial year 2008. Highlights: * The global biotechnology market generated total revenues of $171.8 billion in 2007, representing a compound annual growth rate (CAGR) of 10.7% for the period spanning 2003-07. The performance of the market is forecast to decelerate, with an anticipated CAGR of 9.9% for the five-year period 2007-12, which is expected to drive the market to a value of $275.8 billion by the end of 2012. * The top 10 global biotechnology companies recorded revenues of $56.7 billion during 2008, an increase of 12.6% over FY2007. The operating profit of these companies was $15.1 billion in FY2008, an increase of 12.1% over FY2007. The net profit was $10.5 billion during FY2008, an increase of 10.3% over FY2007. * The average operating margin of the top 10 companies was 17% in FY2008 as compared with that of 20.2% in FY2007. The net margin was 10.3% in 2008 as compared with that of 14.9% in 2007. * Since 2003, the global biotechnology market has witnessed a significant growth across different geographies. However, the market growth is expected to decelerate for next few years due to increased number of patent expiries and intensifying competition from biosimilars. Reasons to Purchase * Gain insights into the industry, leading companies and competitors through a single report * Benchmark the leading players using 5-year financial analysis, ratios and adjusted financial statement data * Form opinions about key players using SWOT Analysis to understand internal factors (strengths and weaknesses) and external factors (opportunities and threats) influencing the companies * Determine industry attractiveness from five-forces analysis of constituent segments. Key Topics Covered: Executive Summary * Industry analysis * Industry definition * Research highlights * Top 10 companies landscape Market Value * Market Forecast * Market Segmentation-Product * Market Segmentation-Geographic Five Forces Analysis * Summary * Buyer power * Supplier power * New entrants * Substitutes * Rivalry Top 10 Companies Landscape * Revenue analysis * Financial performance analysis Company Reports * Amgen * Genentech * Gilead Sciences * UCB * Genzyme * Biogen Idec * CSL * Celgene * Cephalon * Actelion * Financial Analysis * Amgen * Genentech * Gilead Sciences * UCB * Genzyme * Biogen Idec * CSL * Celgene * Cephalon * Actelion Appendix For more information visit http://www.researchandmarkets.com/research/1baa00/global_top_10_biot Source: Datamonitor Research and Markets Laura Wood, Senior Manager U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 press@researchandmarkets.com Copyright Business Wire 2009
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.
Follow Reuters